id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
CMS-2022-0171-0001,CMS,CMS-2022-0171,Medicare Advantage and Prescription Drug Program: Final Marketing Provisions (CMS-10260),Notice,,2022-10-21T04:00:00Z,2022,10,2022-10-21T04:00:00Z,,2022-11-02T15:22:19Z,2022-22844,0,0,0900006485442a2b